In bladder cancer, increased expression of NCL boosts its aggressiveness and promotes its pulmonary metastasis [161], whereas blocking NCL expression in bladder cancer can inhibit bladder cancer proliferation and invasion [162,163,164]. Here, NUCLEOLIN is linked to urinary bladder cancer.